Lombard Odier Asset Management (USA)’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-97,200
Closed -$1.53M 521
2022
Q2
$1.53M Hold
97,200
0.06% 178
2022
Q1
$1.48M Buy
97,200
+22,200
+30% +$338K 0.05% 149
2021
Q4
$1.15M Buy
+75,000
New +$987K 0.05% 152
2018
Q1
Sell
-15,834
Closed -$104K 263
2017
Q4
$104K Sell
15,834
-1,466,515
-99% -$8.96M 0.01% 209
2017
Q3
$8.24M Buy
1,482,349
+514,477
+53% +$3.47M 0.59% 58
2017
Q2
$7.47M Buy
967,872
+647,872
+202% +$5.47M 0.59% 53
2017
Q1
$2.88M Buy
+320,000
New +$3.34M 0.27% 106

Other funds holding NPTN

Lombard Odier Asset Management (USA)'s NPTN Position: Q3 2022 in Review

Lombard Odier Asset Management (USA) sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 97,200 shares — an estimated $1.53M sold.

Lombard Odier Asset Management (USA) first reported a position in NPTN in Q1 2017 and held it in 7 quarters. The position peaked at $8.24M in Q3 2017. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Lombard Odier Asset Management (USA) reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 97,200 NEOPHOTONICS CORP shares in Q3 2022, an estimated $1.53M.
  • Lombard Odier Asset Management (USA) first reported a position in NEOPHOTONICS CORP in Q1 2017 and held it in 7 quarters.
  • Lombard Odier Asset Management (USA)'s NEOPHOTONICS CORP position peaked at $8.24M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2022, filed 14 Nov 2022.